RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
  Dermatitis
  Pemphigus
  Psoriasis
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Dermatology Channel

subscribe to Dermatology newsletter
Latest Research : Dermatology

   EMAIL   |   PRINT
Recurrent melanoma may be more common than previously thought

Apr 18, 2006 - 2:23:00 PM , Reviewed by: Priya Saxena
"These findings, which indicate a higher frequency of second primary melanomas than suggested by previous studies, also underscore the importance of close surveillance of patients with melanoma."

 
[RxPG] Approximately 8 percent of patients with melanoma skin cancer may develop an additional melanoma within two years of their initial diagnosis, and those with atypical moles appear to be at higher risk, according to an article in the April issue of Archives of Dermatology, one of the JAMA/Archives journals.

Cutaneous (skin) melanoma begins in cells known as melanocytes, which produce the pigment that gives skin its color. Previous studies have evaluated the recurrence of melanoma among patients already diagnosed with the disease; most have estimated that less than 4 percent of them will develop additional tumors in the year following diagnosis, according to background information in the article.

Linda Titus-Ernstoff, Ph.D., Dartmouth Medical School, Lebanon, N.H., and colleagues assessed the frequency of and risk factors for recurring cancer among 354 New Hampshire residents with a first diagnosis of cutaneous melanoma. Participants completed a 40-minute telephone interview, during which they answered questions about medical history, demographics, eye and hair color, sun exposure and whether their skin tanned, burned or freckled in the sun. They then underwent a skin examination, during which a physician identified and catalogued benign and atypical moles. Atypical moles have at least three of the following features: a diameter larger than 5 millimeters, redness, an irregular or ill-defined border, a variety of colors or a portion that is flat.

By examining pathology records, the researchers found that 20 (6 percent) of the participants developed an additional melanoma within one year of diagnosis and 27 (8 percent) developed an additional melanoma within two years. Sixty-three percent of those who developed additional tumors and 37 percent of those who did not had at least one atypical mole. The more atypical moles an individual had, the more likely he or she was to develop additional melanomas--three or more atypical moles indicated four times the risk. Lifetime history of sun exposure did not appear to influence the risk of recurring melanoma. However, those with a history of sunburn were less likely to develop a second melanoma than those without, a finding that "must be viewed cautiously," the researchers write. Those who are predisposed to develop multiple melanomas may be less susceptible to sunburn than those with one melanoma, or they may be more likely to avoid sun exposure. "In any case, the association should not be construed as suggesting that sunburn protects patients with melanoma from developing additional tumors," the authors continue.

"The importance of studying risk for additional primary tumors within a defined population-based study group is underscored by our findings," they conclude. "These findings, which indicate a higher frequency of second primary melanomas than suggested by previous studies, also underscore the importance of close surveillance of patients with melanoma."




Publication: Arch Dermatol. 2006; 142:433-438
On the web: pubs.ama-assn.org 

Advertise in this space for $10 per month. Contact us today.


Related Dermatology News
Scientists identify genetic cause of 'spongy' skin condition
Capability of curry component to treat disease merits US patent
Treatment with anti-TNFs can increase the risk of shingles by up to 75 percent
Psoriasis is associated with impaired HDL function, Penn study finds
New approaches to skin cancer prevention
What the doctor prescribes: Customized medical-image databases
NIH awards National Jewish Health $31 million to lead study of infections associated with eczema
More than skin deep, tanning product of sun's rays
Drug could provide first treatment for scleroderma
Alzheimer's, asthma, cancer, malaria and TB focus of new Singapore grants

Subscribe to Dermatology Newsletter

Enter your email address:


 Additional information about the news article
This project was supported by a grant from the National Cancer Institute, Bethesda, Md.

 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)